Future directions vasodilator therapy heart failure Vasodilator therapy major pharmacologic approach ventricular function vasodilator drugs treatment heart failure Ideally vasodilator drugs long-term management heart failure pharmacodynamic effects reduced impedance ventricular ejection venous capacitance ventricular ejection fraction reduced heart size absence neurohormonal stimulation progression left ventricular dysfunction mechanisms action sites activity various vasodilator drugs available vary none ideal treatment heart failure hypertension complexity multiple vasoconstrictor mechanisms heart failure rationale combined vasodilator therapy certain combinations therapeutic standpoint development drugs multiple mechanisms action attractive Flosequinan new vasodilator agent cellular mechanism action uncertain Flosequinan advantage able arterial venous beds beneficial treatment heart failure 